Sanofi (LON: 0A2V)

Market Cap	104.31B
Revenue (ttm)	40.31B
Net Income (ttm)	3.75B
Shares Out	n/a
EPS (ttm)	2.99
PE Ratio	27.82
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	May 9, 2024

Volume	3,947
Average Volume	3,699
Open	50.98
Previous Close	50.56
Day's Range	50.94 - 51.76
52-Week Range	35.79 - 46.86
Beta	n/a
RSI	65.46
Earnings Date	Jan 30, 2025

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric ...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 86,088
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A2V

Financial Performance

In 2023, Sanofi's revenue was 46.03 billion, an increase of 1.42% compared to the previous year's 45.39 billion. Earnings were 5.40 billion, a decrease of -35.49%.

Financial numbers in EUR